The MVA85A trial advanced scientific understanding, brought together a talented group of scientists who are dedicated to accelerating TB vaccine research, and built the research infrastructure – from laboratories and clinics to global collaborative partnerships
–required to identify and evaluate promising candidates using the highest international standards.
Full Blog Post ›